Detalhe da pesquisa
1.
The landscape of alternative polyadenylation during EMT and its regulation by the RNA-binding protein Quaking.
RNA Biol
; 21(1): 1-11, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112323
2.
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation.
Breast Cancer Res
; 24(1): 8, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078508
3.
miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking.
EMBO J
; 37(13)2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29871889
4.
Differential subcellular and extracellular localisations of proteins required for insulin-like growth factor- and extracellular matrix-induced signalling events in breast cancer progression.
BMC Cancer
; 14: 627, 2014 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25167778
5.
Quaking isoforms cooperate to promote the mesenchymal phenotype.
Mol Biol Cell
; 35(2): ar17, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019605
6.
Vitronectin--master controller or micromanager?
IUBMB Life
; 65(10): 807-18, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030926
7.
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
Proc Natl Acad Sci U S A
; 107(35): 15449-54, 2010 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-20713713
8.
Gene expression based inference of cancer drug sensitivity.
Nat Commun
; 13(1): 5680, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167836
9.
Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer.
Cancers (Basel)
; 13(5)2021 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803139
10.
Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin.
Growth Factors
; 28(5): 359-69, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20569097
11.
The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
J Mammary Gland Biol Neoplasia
; 14(1): 29-43, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19242781
12.
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer.
Clin Cancer Res
; 26(7): 1678-1689, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919137
13.
Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2.
Front Endocrinol (Lausanne)
; 10: 481, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31379747
14.
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.
Oncogene
; 38(7): 913-934, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194451
15.
Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.
Oncogene
; 38(13): 2436, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510231
16.
Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor.
Endocrinology
; 149(3): 1075-90, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18079201
17.
Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma Progression.
Sci Rep
; 8(1): 583, 2018 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330502
18.
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.
Int J Pharm
; 532(1): 511-518, 2017 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916296
19.
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.
Oncotarget
; 8(12): 18949-18967, 2017 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28145883
20.
Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.
Clin Exp Metastasis
; 33(4): 385-99, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26932199